Titan Pharma (TTNP) |
|
0.1771 -0.013 (-6.74%)
|
11-29 21:21 |
|
Open: |
0.18645 |
Pre. Close: |
0.1899 |
|
High:
|
0.1885 |
Low:
|
0.176 |
|
Volume:
|
35,396,070 |
Market Cap:
|
35M |
|
|
|
|
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform that focuses primarily on the treatment for chronic diseases. The company also develops ProNeura-Ropinirole, an implant to provide delivery of ropinirole, a dopamine agonist for the treatment of Parkinson's disease; and triiodothyronine, an implant for the treatment of hypothyroidism. Titan Pharmaceuticals, Inc. was incorporated in 1992 and is based in South San Francisco, California. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.19 - 0.191 |
0.191 - 0.192 |
|
Low:
|
0.177 - 0.178 |
0.178 - 0.18 |
|
Close:
|
0.178 - 0.18 |
0.18 - 0.181 |
|
Technical analysis |
as of: 2020-11-29 9:28:37 AM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 0.26 One year: 0.35 |
| Support: |
Support1: 0.09 Support2: 0.07 |
| Resistance: |
Resistance1: 0.22 Resistance2: 0.30 |
| Pivot: |
0.14  |
| Moving Average: |
MA(5): 0.18 MA(20): 0.14
MA(100): 0.21 MA(250): 0.24 |
| MACD: |
MACD(12,26): 0.01 Signal(9): |
| Stochastic oscillator: |
%K(14,3): 42.40 %D(3): 43.23 |
| RSI: |
RSI(14): 57.88 |
| 52-week: |
High: 0.55 Low: 0.09 Change(%): 18.1 |
| Average Vol(K): |
3-Month: 3753649 10-Days: 12071166 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.TTNP has closed below upper band by 24.4%. Bollinger Bands are 71.7% wider than normal. The large width of the bands suggest high volatility as compared to TTNP's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Fri, 27 Nov 2020
Titan Pharmaceuticals Inc. (TTNP) Plunges 6.74% on November 27 - Equities.com
Fri, 27 Nov 2020
Here is why Titan Pharmaceuticals Inc. (TTNP) recent weekly performance of 49.65% shouldn’t bother you at All - The InvestChronicle
Thu, 26 Nov 2020
Titan Pharmaceuticals Inc. (TTNP) Soars 14.05% on November 26 - Equities.com
Mon, 23 Nov 2020
Titan Pharmaceuticals Inc. [TTNP] Stock trading around $0.20 per share: What’s Next? - The DBT News
Fri, 20 Nov 2020
Titan Pharmaceuticals, Idera Pharmaceuticals leads healthcare gainers; AVROBIO, Stealth BioTherapeutics among losers - Seeking Alpha
Fri, 20 Nov 2020
TTNP Stock Price Increases 34.75%: Why It Happened - Pulse 2.0
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
197 |
| Shares Float (M) |
97 |
|
% Held by Insiders
|
5.08 |
|
% Held by Institutions
|
6.09 |
|
Shares Short (K)
|
14,790 |
|
Shares Short P. Month (K)
|
6,420 |
Stock Financials |
|
EPS
|
-0.281 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
0.020 |
|
Profit Margin
|
|
|
Operating Margin
|
-337.58 |
|
Return on Assets (ttm)
|
-123.2 |
|
Return on Equity (ttm)
|
-3431.6 |
|
Qtrly Rev. Growth
|
163.9 |
|
Gross Profit (p.s.)
|
-0.025 |
|
Sales Per Share
|
0.025 |
|
EBITDA (p.s.)
|
-0.082 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-16 |
|
Levered Free Cash Flow (M)
|
-11 |
Stock Valuations |
|
PE Ratio
|
-0.63 |
|
PEG Ratio
|
|
|
Price to Book value
|
8.86 |
|
Price to Sales
|
7.21 |
|
Price to Cash Flow
|
-2.15 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
